GlassScriptPhysician profile
Lori L Warren
NPI 1437242062
$217,770.36
in general payments reported to CMS, 2019-2025
32 companies · $1,481 in 2025
The $1,481 reported for 2025 was more than what 87% of Gynecology providers received nationally (typical 2025 total: $162).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $95K · 2020: $35K · 2021: $37K · 2022: $33K · 2023: $16K · 2024: $268 · 2025: $1,481.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $15K · Travel and Lodging: $1,430 · Food and Beverage: $1,328.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $14,641.23 |
| Travel and Lodging | $1,429.94 |
| Food and Beverage | $1,328.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $140,751.93 | 2019-2023 | Enseal, Dermabond, Harmonic |
| Abbvie INC. | $46,286.40 | 2019-2022 | |
| Hologic Sales and Service, LLC | $13,494.88 | 2019-2025 | Acessa Provu System, Myosure Tissue Removal Device, Novasure |
| Myovant Sciences INC. | $4,943.25 | 2021-2022 | |
| Coloplast Corp | $3,543.89 | 2019-2025 | |
| Ethicon US, LLC | $2,388.04 | 2019-2023 | Harmonic, Enseal X1 |
| Mdd US Operations, LLC | $1,750.00 | 2019 | |
| Escala Medical INC. | $862.46 | 2025 | |
| Acessa Health INC. | $500.00 | 2021 | |
| Medtronic USA, INC. | $334.04 | 2019 | |
| Baxter Healthcare | $320.61 | 2021-2024 | Tisseel |
| Asensus Surgical, INC. | $296.92 | 2019 | |
| Caldera Medical, INC | $279.16 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $275.23 | 2020-2022 | |
| Aspira Women'S Health INC | $265.39 | 2021-2022 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Femselect INC. | $260.88 | 2025 | Enplace |
| Astellas Pharma US INC | $209.99 | 2019-2021 | |
| Minerva Surgical, INC | $206.94 | 2019-2025 | |
| Axonics, INC. | $149.29 | 2021 | |
| Arthrex, INC. | $126.50 | 2025 | |
| Sumitomo Pharma America, INC. | $117.32 | 2024-2025 | Myfembree |
| Mayne Pharma Commercial LLC | $83.56 | 2022 | |
| Exeltis, USA INC. | $65.46 | 2022 | |
| Coopersurgical, INC. | $64.05 | 2019 | |
| Evofem Biosciences, INC. | $40.22 | 2022 | |
| Therapeuticsmd, INC. | $36.09 | 2022 | |
| Astellas Pharma Global Development | $34.44 | 2024 | Veozah |
| Agile Therapeutics, INC. | $30.02 | 2022 | |
| Pfizer INC. | $14.98 | 2019 | |
| Lupin INC. | $14.63 | 2019 | |
| Organon LLC | $12.49 | 2021 | |
| Amgen INC. | $11.30 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lori Warren listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.